JenaValve announced that it received FDA premarket approval (PMA) for its Trilogy THV system.
Trilogy, a transcatheter heart valve (THV) system, won approval for the treatment of patients with symptomatic, severe aortic regurgitation (AR) at...
JenaValve announced that it received FDA premarket approval (PMA) for its Trilogy THV system.
Trilogy, a transcatheter heart valve (THV) system, won approval for the...
GE HealthCare announced that it completed its previously announced $2.3 billion acquisition of Intelerad.
Chicago-based GE HealthCare announced in November that it agreed to buy...
Nia Therapeutics announced that it received FDA breakthrough device designation for its Smart Neurostimulation System (SNS).
The device won the breakthrough nod for the treatment...
Imperative Care announced that it closed an oversubscribed convertible note financing totaling $100 million.
New investors, Elevage Medical Technologies and Perceptive Advisors, co-led the financing...
Senseonics announced new data from a real-world study demonstrating the sustained performance of its Eversense 365 CGM.
Real-world evidence demonstrated the long-term performance and positive...
Arsenal Medical, a clinical-stage company pioneering innovative biomaterials-based devices, announced the first patient treated with a first-of-its-kind device, ResQFoam™, in the REVIVE clinical study...
TECLens has commenced the first-in-human clinical trial assessing its quantitative corneal crosslinking (qCXL) technology for non-invasive refractive vision correction, administering treatment to the initial...
VESTECK announced that implanting clinicians will present two-year follow-up data from the company’s first-in-human experience with the SUTURE-TIGHT™ Endovascular Catheter System, an adjunctive fixation...
JenaValve announced that it received FDA premarket approval (PMA) for its Trilogy THV system.
Trilogy, a transcatheter heart valve (THV) system, won approval for the...
GE HealthCare announced that it completed its previously announced $2.3 billion acquisition of Intelerad.
Chicago-based GE HealthCare announced in November that it agreed to buy...
Nia Therapeutics announced that it received FDA breakthrough device designation for its Smart Neurostimulation System (SNS).
The device won the breakthrough nod for the treatment...
Imperative Care announced that it closed an oversubscribed convertible note financing totaling $100 million.
New investors, Elevage Medical Technologies and Perceptive Advisors, co-led the financing...